Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DE-127 ophthalmic solution dose-ranging confirmatory study in pediatric myopia
CTR20220631Phase 3Completed
- Sponsor
- Santen Pharmaceutical
- Start
- Jun 2022
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atropine in myopia, sponsored by Santen Pharmaceutical. Started Jun 2022; status: completed.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on CTR20220631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220631.